I should say, nothing at all wrong with directors recommending an offer as fair and reasonable - whilst they themselves aren't participating.
Everyone has different circumstances and outlooks.
For one, many directors might hold the view that it is appropriate they have 'skin in the game' whilst being on the board. Following on, they may see the value in the bid but have a 'blue sky' view of the future (as listed in the reasons not to sell, they might personally hold the view that chemical sunscreens get banned). They might also just be having a high income year so from a tax point of view don't want to realise a big capital gain etc.
I guess it might be interesting to know their personal thoughts as to why - but they have every right to go, we've assessed the independent expert report, consider it fair and reasonable and recommend you accept, but then (for their own circumstances) not participate personally.
- Forums
- ASX - By Stock
- Ann: Supplementary Target's Statement
ANO
advance zinctek limited
Add to My Watchlist
0.00%
!
78.0¢

I should say, nothing at all wrong with directors recommending...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
78.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.86M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1922 | 78.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
79.0¢ | 6999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1922 | 0.780 |
1 | 825 | 0.775 |
2 | 26835 | 0.770 |
1 | 1371 | 0.725 |
2 | 62274 | 0.720 |
Price($) | Vol. | No. |
---|---|---|
0.790 | 6999 | 1 |
0.800 | 5994 | 2 |
0.820 | 7363 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
ANO (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online